Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2002
05/23/2002US20020061528 Expression vector; for use in the controlled expression genes
05/23/2002US20020061527 Human DNA topoisomerase I alpha
05/23/2002US20020061524 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same
05/23/2002US20020061522 1983, 52881, 2398, 45449, 50289, and 52872 novel G protein-coupled receptors and uses therefor
05/23/2002US20020061517 Adenovirus carrying gag gene HIV vaccine
05/23/2002US20020061516 Amplifying and recoveving viral nucleic acids; obtain viral nucleotide sequences, incubate with primers, expose to polymerase, recover and count amplified product
05/23/2002US20020061515 Model for neurodegenerative diseases involving amyloid accumulation
05/23/2002US20020061513 Isolation of preferential cellular components; obtain genetically engineered cells, express vector, detect polypeptides on support, recover polypeptides
05/23/2002US20020061512 Zinc finger domains and methods of identifying same
05/23/2002US20020061511 Assay for ABCA1
05/23/2002US20020061310 Compositions and methods for dendritic cell-based immunotherapy
05/23/2002US20020061309 Production of peptides in plants as N-terminal viral coat protein fusions
05/23/2002US20020061307 Polyalkylene oxide-modified single chain polypeptides
05/23/2002US20020061306 DNA sequences encoding proteins having ability to bind alpha 2-macroglobulin; expression vectors; immunology
05/23/2002US20020061299 Protecting tissues from ischemia/reperfusion injury via introducing/ expressing gene construct encoding thereapeutic antioxidant
05/23/2002US20020061297 Novel recombinant DNA vectors for gene therapy
05/23/2002US20020061296 Nond-denatured apoptin (with fusion protein or tag) as anticancer, anti-autoimmune disease therapeutic proteins (HIV TAT proteins)
05/23/2002US20020061295 Myocardial grafts and cellular compositions useful for same
05/23/2002US20020061294 Mononuclear phagocytes in therapeutic drug delivery
05/23/2002US20020061293 Transduced human hematopoietic stem cells
05/23/2002US20020061291 For screening potential drugs for toxicity toward introduced cells or capacity to stimulate differentiation and/or proliferation; cancer diagnosis
05/23/2002US20020061287 Process of making a compound by forming a polymer from a template drug
05/23/2002US20020061262 Transparent substrate with two parallel flat surfaces, one of the surfaces forming an active surface; a base with central window opening and registration surface,a gasket, and a press block
05/23/2002US20020060284 Photo-detecting apparatus
05/23/2002US20020060156 Glassine monolithic microvolume PCR-CE device utitilizing thin film metal heater to maintain a predetermined range of temperature for desired denaturations; thermocouples assure requisite cycling of sub- microliter PCR volumes.
05/23/2002DE10126367A1 Pharmaceutical composition comprises Borrelia antigens and encoding nucleic acid, useful for diagnosis, treatment and prevention of Lyme borreliosis
05/23/2002DE10125089A1 New polynucleotide representing mtrA and B genes of coryneform bacteria, useful, when suppressed, for increasing fermentative production of amino acids
05/23/2002DE10057801A1 New polynucleotide encoding the CysQ transporter of coryneform bacteria, useful, when over expressed, for increasing fermentative production of amino acids
05/23/2002DE10057755A1 New nucleic acid encoding plant phosphomevalonate kinase, useful for identifying modulators, potentially useful as herbicides and growth regulators
05/23/2002DE10055512A1 L-Aminosäure-Oxidase aus Rhodococcus-Arten L-amino acid oxidase from Rhodococcus species
05/23/2002DE10050022C1 Selecting embryogenic plant cells, useful e.g. for determining regenerative potential of in vitro cultures, by expressing artificial embryogenic marker gene
05/23/2002CA2749307A1 Promoter sequence of a gene encoding an exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2707684A1 Novel exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2632696A1 Modified clostridial neurotoxins with altered biological persistence
05/23/2002CA2467360A1 Exoenzyme toxin of aeromonas salmonicida, and uses therefor
05/23/2002CA2467309A1 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
05/23/2002CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof
05/23/2002CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof
05/23/2002CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
05/23/2002CA2429458A1 Process for producing coenzyme q10
05/23/2002CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same
05/23/2002CA2429342A1 Promoters exhibiting endothelial cell specificity and methods of using same
05/23/2002CA2429214A1 Guanosine triphosphate (gtp)-binding protein-coupled receptor protein, bg37
05/23/2002CA2429210A1 Expression system for recombinant proteins
05/23/2002CA2429195A1 Immunoglobulin superfamily proteins
05/23/2002CA2429144A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
05/23/2002CA2429142A1 Maize yellow stripe1 and related genes
05/23/2002CA2429031A1 Regulation of flavonoid expression in alfalfa using maize regulatory genes
05/23/2002CA2428850A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
05/23/2002CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
05/23/2002CA2428716A1 Method to identify genes associated with chronic myelogenous leukemia
05/23/2002CA2428643A1 Methods for large scale protein production in prokaryotes
05/23/2002CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain
05/23/2002CA2428136A1 Modified clostridial neurotoxins with altered biological persistence
05/23/2002CA2427902A1 Compositions and methods for the therapy and diagnosis of ovarian cancer
05/23/2002CA2427010A1 Transporters and ion channels
05/23/2002CA2426100A1 Metabolic rate shifts in fermentations expressing recombinant proteins
05/23/2002CA2420983A1 Molecules for disease detection and treatment
05/22/2002EP1207383A2 Method of making high density arrays
05/22/2002EP1207208A2 Method for preservation of cells and nucleic acid targets
05/22/2002EP1207207A1 Process for immobilization of nucleic acid molecules on a substrate
05/22/2002EP1207205A1 Adenoviral replicons
05/22/2002EP1207204A1 Tissue-specific promoters from sugar beet
05/22/2002EP1207203A2 DNA sequence and papillomavirus vaccine
05/22/2002EP1207202A1 Nucleic acid molecules encoding a protein interacting with the chemokine receptor CCR5 or other chemokine receptor family members
05/22/2002EP1207201A1 Novel g protein-coupled receptor protein and dna thereof
05/22/2002EP1207200A1 High affinity choline transporter
05/22/2002EP1207199A1 Tumor antigen
05/22/2002EP1207196A1 Immortalized preosteoblasts and method for their production
05/22/2002EP1207169A1 Novel g protein-coupled receptor protein and dna thereof
05/22/2002EP1207168A1 Polypeptides and nucleic acids encoding the same
05/22/2002EP1206906A1 Mouse having human cytochrome p450 transferred therein
05/22/2002EP1206701A1 Antigenic components of selected indicator fungi and their use in methods and test kits
05/22/2002EP1206579A1 Preparation of metal oxide supports loaded with biomolecules
05/22/2002EP1206577A2 Binary encoded sequence tags
05/22/2002EP1206576A1 Novel kinases and uses thereof
05/22/2002EP1206575A1 Transcription-free selex
05/22/2002EP1206573A1 26 human secreted proteins
05/22/2002EP1206571A2 Rapid and efficient capture of dna from sample without using cell lysing reagent
05/22/2002EP1206570A1 Screening for udp-glucose:glycoprotein glucosyltransferase (uggt) activity
05/22/2002EP1206566A2 Bacteriophage library useful for typing bacteria and system and method utilizing same
05/22/2002EP1206563A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof
05/22/2002EP1206562A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing
05/22/2002EP1206561A2 Method for production of proteinaceous substances
05/22/2002EP1206560A2 Plant gene expression, controlled by constitutive plant v-atpase promoters
05/22/2002EP1206559A2 Conditional inhibition of vegetative propagation
05/22/2002EP1206558A2 Plants with modified polyunsaturated fatty acids
05/22/2002EP1206557A2 Plant defensin variants
05/22/2002EP1206556A2 Method of isolating secretion signals in lactic acid bacteria, and secretion signals isolated from lactococcus lactis
05/22/2002EP1206554A1 Activatable recombinant neurotoxins
05/22/2002EP1206553A2 Isomerase proteins
05/22/2002EP1206552A2 Tryptase-like polypeptide ztryp1
05/22/2002EP1206551A2 Enzymatic synthesis of deoxyribonucleosides
05/22/2002EP1206550A1 Proteins derived from white spot syndrome virus and uses thereof
05/22/2002EP1206549A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis
05/22/2002EP1206548A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis
05/22/2002EP1206547A2 Moraxella catarrhalis antigen basb117
05/22/2002EP1206546A2 Moraxella catarrhalis antigen basb120
05/22/2002EP1206545A1 Basb116 dna and proteins from moraxella catarrhalis
05/22/2002EP1206544A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof